Рет қаралды 157
Welcome to Clot Chronicles, a series highlighting contributions from our Executive and Medical Advisory Boards to keep you up to date on the latest thrombosis research. Along with concise, clinically focused summaries, you'll also have access to videos featuring our board members and their work.
In this breaking news video, NATF Advisory Board Member, Behnood Bikdeli, MD, MS, and NATF President, Christian Ruff, MD, MPH, discuss the AZALEA trial, which was presented as late-breaking science at the American Heart Association Scientific Sessions this past weekend.